Mild to Moderate Asthma Clinical Trials

8 clinical trials for Mild to Moderate Asthma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma — RECRUITING · PHASE1
• A Study of CDX-622 in Participants With Mild to Moderate Asthma — RECRUITING · PHASE1
• Remission in Adults With Mild-to-moderate Asthma in Thailand — RECRUITING
• A Phase 1b, Double-Blind Study to Investigate Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of Single Dose of ATI-052 in Participants with Mild to Moderate Asthma — TERMINATED · PHASE1
• A Phase II, multinational, multicentre, double-blind, randomised, active-controlled, 3-way cross-over study to evaluate the therapeutic equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a versus CHF5993 pMDI 100/6/12.5 µg HFA-134a in subjects with mild to moderate asthma. [TRECONY] — TERMINATED · PHASE2
• Phase 1, Randomized, Double-blind, Placebo-Controlled, First-in-Human Single Ascending Dose Study in Healthy Participants to Assess the Safety, Tolerability, and Pharmacokinetics of JNJ-95597528 and a Proof of Mechanism Study in Participants with Mild to Moderate Asthma — TERMINATED · PHASE1
• A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2) — COMPLETED · PHASE1
• Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma — COMPLETED · PHASE2

Refine this search